Migraine-headache and essential arterial hypertension. A clinical pharmacological approach with the false transmitter metaraminol.
D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006261:Headache / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000150:complications*; D008680:Metaraminol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008881:Migraine Disorders / Q000209:etiology; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009638:Norepinephrine; D010646:Phentolamine / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008680:Metaraminol; D009638:Norepinephrine; D010646:Phentolamine